Skip to main content

Paternal Antiseizure Rx Use at Conception Does Not Pose Risk to Offspring

Medically reviewed by Carmen Pope, BPharm. Last updated on Sep 23, 2024.

By Elana Gotkine HealthDay Reporter

MONDAY, Sept. 23, 2024 -- Limited data indicate that paternal exposure to antiseizure medications (ASMs) at conception is unlikely to pose any major risk for adverse outcomes for offspring, according to a review published online Sept. 17 in the Journal of Neurology, Neurosurgery & Psychiatry.

Eliza Honybun, from the University of Melbourne in Australia, and colleagues conducted a systematic review to assess neurodevelopmental and anatomical outcomes in offspring born to fathers taking ASMs at the time of conception. Twenty-six studies underwent full-text review; 10 met the eligibility criteria for inclusion.

The researchers found limited evidence was available, and no clear evidence was found for an adverse impact of paternal ASM use on offspring outcomes. The few isolated adverse findings were not seen in other studies. A meta-analysis was prevented by several methodological limitations, including failure to report outcomes separately for each individual ASM, heterogeneity in measurement and outcome reporting, and small numbers of monotherapy exposures.

"While the findings summarized in our systematic review are overall reassuring for males taking ASMs, including valproate, it is clear that the potential reproductive implications of ASM exposure in males remain an underinvestigated area of research that should be prioritized over the next decade," the authors write.

Several authors disclosed ties to the pharmaceutical industry.

Abstract/Full Text

Editorial

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Posted September 2024

Read this next

More Than 3.6 Million Births Recorded in the United States in 2024, Up 1 Percent From 2023

WEDNESDAY, April 23, 2025 -- In 2024, the provisional number of births in the United States was 3,622,673, which was 1 percent higher than in 2023, according to an April Vital...

Maternal Anemia in Early Pregnancy May Increase Risk for Congenital Heart Disease

WEDNESDAY, April 23, 2025 -- Maternal anemia in early pregnancy is associated with an increased risk for congenital heart disease (CHD) in offspring, according to a study...

New Definition of Epilepsy Improves Diagnosis, Treatment

TUESDAY, April 15, 2025 -- The new International League Against Epilepsy (ILAE) definition of epilepsy results in a higher frequency of epilepsy diagnosis and treatment, according...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.